AzTrials
AzTrials

Evaluate CBCT Protocols in Subjective Image QualityNCT05351372

Validation of X-ray Protocols in Cleft Children

A study testing Ultra-low dose protocol and Standard dose protocol in people with Evaluate CBCT Protocols in Subjective Image Quality, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Children born with an alveolar cleft receive bone grafts for improved function and aesthetics. The cleft area is radiologically examined before and post bone graft. Optimizing x-ray examination protocols is essential to protect these patients from possible delayed radiation injury later in life. Read more about this study

Who is it for?
Any age
What is being tested?
Ultra-low dose protocol and Standard dose protocol
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteSweden
Study dates
31 May 2016to 18 May 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients with cleft involving the alveolar process undergoing treatment at Stockholm Craniofacial Centre
  • Reason for referral is CBCT examination in order to evaluate anatomy of the anterior maxilla prior to or after bone augmentation of the cleft
  • Patient/parent has given informed consent to participate in the study.

Who cannot join

  • No informed consent is given. Those patients will be examined according to standard clinical procedures.
  • Patients with a medical history of disorder/syndrome/chronic disease that will affect both the examination and the outcome.
  • No CBCT examination of the cleft area.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institutet

    Stockholm, 14154

Other trials in Sweden

About this study

Official title: Low-dose Cone-beam Computed Tomography for Assessment of Alveolar Clefts, a Randomized Controlled Trial in Image Quality

Children born with an alveolar cleft receive bone grafts for improved function and aesthetics. The cleft area is radiologically examined before and post bone graft. Optimizing x-ray examination protocols is essential to protect these patients from possible delayed radiation injury later in life. This study investigates whether image quality of cone-beam computed tomography (CBCT) exposed with an ultra-low dose (ULD) protocol is comparable to the clinical default protocol, the standard dose (SD) protocol, in visualizing details of importance in bone grafting of alveolar clefts.

Methods In this randomized controlled study, 72 patients with uni- or bilateral alveolar clefts between 9-19 years (mean age 9.5) were randomized 1:1 with either a ULD or an SD CBCT examination protocol. The CBCT scans were conducted with Planmeca ProMax Mid with an 8x5cm field of view. Two experienced radiologists blindly evaluated the images and visibility of cortical bone border, trabecular bone, tooth anatomy, root development, periodontal space, and cleft width. The visibility was categorized as unacceptable, acceptable, or excellent.

Read the detailed description

Radiographic imaging is an integral part of diagnostics, therapy planning and post-surgery assessment. Cone beam computed tomography (CBCT) was introduced in the late 90s and is now widely accepted. The technique utilizes a cone shaped X-ray beam to directly create a volumetric data, with predefined fields of view (FOV). CBCT provides 3D information with excellent spatial resolution, enabling assessment of anatomical variations and pathological changes in bone.

Cleft lip and palate disorder are among the most common birth defects, with the reported incidence in the Stockholm region of 1.7/1000 live births. The malformation can involve the lip, the alveolar process and the palate. When the alveolar process is involved CBCT can be indicated to assess the local anatomy prior to and after bone augmentation.

Minimizing the radiation dosage is especially important for children since the estimated risk for cancer formation or hereditable effects is approximately 3 times higher than for an adult aged 30.

Therefore the developments of low dose protocols within CBCT techniques are progressing rapidly. By applying more sensitive detector and a sophisticated image processing algorithm, the manufacturer Planmeca claimed that with Ultra Low Dose (ULD) protocol the effective patient dose may be reduced by up to 76%. A consequence of dramatically reduced exposure is the decreased signal-noise ratio, in other words reduced image quality, which results in increased diagnostic uncertainty of detailed structures. Since the accepted diagnostic image quality is highly associated with diagnostic tasks, clinical studies on evaluation new diagnostic feature are important.

HYPOTHESIS/RESEARCH QUESTION Will Promax 3D Mid CBCT with ULD normal dose protocol provide adequate information in order to assess necessary clinical questions in the region of the maxillary alveolar cleft compared to normal dose protocol?

METHODS Study design Randomized controlled trial examining the effect of two different Promax 3D Mid CBCT protocols, i.e. ULD normal dose setting versus normal dose setting, on image quality examining children with cleft involving the alveolar process.

Data source All patients with cleft involving the alveolar process, having treatment at Stockholm Craniofacial Centre Karolinska university hospital, being referred to Division of orofacial diagnostics and surgery - Image and functional odontology, Karolinska Institutet. Reason for referral CBCT examination to evaluate anatomy of the anterior maxilla prior to or after bone augmentation of the cleft located to the alveolar process.

Exposure/Intervention The exposure in the planned study is radiographic examination of children with cleft involving the alveolar process with CBCT Ultra Low Dose protocol compared with Normal dose protocol.

The study will be double blinded, nor will the patient nor the observers performing the evaluation of the images know the allocation. All observer assessment will be performed at one specific computer work station using the software program (Romexis Planmeca OY Helsinki Finland). The examinations will be executed by one of two possible nurses with extensive experience from handling CBCT devices. For the nurse the allocation cannot be concealed since the actual setting of the parameters has to be done manually. Therefore, a triple blinded design seems impossible. Since the same modality is used, Promax 3D Mid CBCT (Planmeca OY Helsinki Finland) for both protocols no evident risk exist that the patient or accompanying parent/guardian will work out the actual protocol in use.

In order to randomize the cases will be sectioned in groups of ten in a 1:1 assignment to either of the two protocols. The sequence for each group will be predetermined by lottery. Ten folded papers with equal size will be drawn by a person blindfolded without any knowledge of the study. The papers will be marked ULD for ULD normal dose protocol respectively NORMAL for normal dose protocol. The sequence for each group will be registered and provided up on the time for examination in a cover in the lab adjacent to the CBCT device. The idea with dividing cases and controls in groups, five of each resulting in a total of ten, is to ensure that the relation between the numbers of the two protocols is balanced.

The image conditions chosen for the Field of View (FOV) is 80mm in diameter and 50mm in height. The reason for not choosing a smaller, FOV i.e. 40 x 50 mm, decreasing the effective dose even further, is to provide information also on the contralateral side of the maxilla, a request from the surgeons giving important information needed during treatment planning. Normal clinical procedure using axial, coronal and sagital reconstructions of 1 mm thick slices will be used for the evaluation. Axial slices are according to standard in 3D imaging reconstructed parallel to the hard palate while paracoronal and parasagittal are perpendicular to the alveolar crest on the cleft side. All reconstructive work and imaging will be made in the software program Romexis (Planmeca OY Helsinki Finland). The examinations and reconstructions will be similar of those in a recent study from Finland in 2014.

Two dentomaxillofacial radiologists with profound knowledge and experience in assessing CBCT images will evaluate all radiographic 3D material. The 3D volumes will randomly be displayed using the same model of monitor (RadiForce MX191; EIZO, Hakusan, Japan), with a built-in digital imaging and communications in medicine setting. The radiographs will be evaluated under dimmed room light and a viewing distance of about 50 cm. The observers are allowed to adjust the window setting for light intensity and contrast according to their own preferences.

According to a three-point scale, the image quality will be assessed based on how well the observers can identify anatomical structures of interest prior to or post bone graft (unacceptable=1, acceptable=2, excellent=3). The landmarks of evaluation will be the cortical border of bone adjacent to the cleft, alveolar bone nearby the cleft, tooth anatomy of teeth adjacent to the cleft, root development, the periodontal space, and the width of the cleft. Possible motion artefacts presented in the CBCT images will be registered as minor or apparent. In case of a discrepancy between the two radiologists, the mean value of the observer's ratings is recorded.

Being tested
Ultra-low dose protocol, Standard dose protocol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultra-low dose protocolRadiation

  • Standard dose protocolRadiation

Study groups in NCT05351372
Study groupRoleWhat they receive
ULD protocolExperimentalultra-low dose protocol in cone-beam computed tomography with a field of view including the cleft area
Receives: Radiation: Ultra-low dose protocol
Standard dose protocolActive comparatorStandard dose protocol in cone-beam computed tomography with a field of view including the cleft area
Receives: Radiation: Standard dose protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective image quality

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

Secondary outcomes (6)
  1. cortical border of bone adjacent to the cleft

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

  2. alveolar bone nearby the cleft

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

  3. tooth anatomy of teeth adjacent to the cleft

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

  4. root development

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

  5. periorontal space visibility

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

  6. Width of the cleft

    unacceptable=1, acceptable=2, excellent=3

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2022
  2. Study start31 May 2016
  3. Primary completion18 May 2017
  4. Study completion18 May 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05351372
Sponsor's protocol ID
853386
Status last verified
Apr 2022
First submitted
22 Apr 2022
Last updated
4 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultra-low dose protocol and Standard dose protocol in people with Evaluate CBCT Protocols in Subjective Image Quality, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective image quality (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2022; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in